Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
Study of the pharmacokinetic and pharmacodynamic variability of mycophenolate mofetil in renal transplant patients already on long-term MMF treatment (at least 6 months post-transplant; at least 3 months in therapy).
Study hypothesis: to investigate whether long-term MMF therapy alters IMPDH biological activity and if there are any correlations with the risk of AR.
|Official Title:||Evaluation of Pharmacokinetic and Pharmacodynamic Parameters in Renal Transplant Patients Receiving Mycophenolic Acid and Stable for at Least 3 Months|
|Study Start Date:||June 2006|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00780429
|IRCCS Fondazione Policlinico San Matteo|
|Pavia, Italy, 27100|